PAMALA TERRY: Open Payments
NPI 1043048200 · BRENTWOOD, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,453 in 122 payments from 19 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $3,453
Food & beverage: $3,453
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 27 | $532 |
| Lilly USA, LLC | 20 | $468 |
| Ardelyx, Inc. | 10 | $418 |
| Novartis Pharmaceuticals Corporation | 13 | $396 |
| Otsuka America Pharmaceutical, Inc. | 14 | $366 |
| Travere Therapeutics, Inc. | 9 | $349 |
| Calliditas Therapeutics US Inc. | 5 | $202 |
| Novo Nordisk Inc | 3 | $167 |
| Dexcom, Inc. | 1 | $146 |
| Vifor Pharma, Inc. | 6 | $139 |
Products named: Kerendia, JARDIANCE, Fabhalta, JYNARQUE, XPHOZAH 30 MG, TARPEYO, IBSRELA, Ozempic.
Industry payments across TN — which companies pay providers there.
